4. As of noon trading, MannKind Corporation ( MNKD) is up $0.52 (7.95) to $7.13 on heavy volume Thus far, 7.4 million shares of MannKind Corporation exchanged hands as compared to its average daily volume of 7.1 million shares. The stock has ranged in price between $6.65-$7.25 after having opened the day at $6.78 as compared to the previous trading day's close of $6.60.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. MannKind Corporation has a market cap of $2.2 billion and is part of the health care sector. Shares are up 226.4% year to date as of the close of trading on Tuesday. Currently there are 3 analysts that rate MannKind Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates MannKind Corporation as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, poor profit margins and weak operating cash flow. Get the full MannKind Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

5 Big Dividend Stocks Billionaire John Paulson Loves

3 Stocks Pulling The Health Services Industry Downward

3 Stocks Pushing The Health Services Industry Higher

3 Health Services Stocks Driving The Industry Higher